Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
+14.4%/yr
vs -13.6%/yr prior
5Y CAGR
+4.7%/yr
Recent acceleration
Acceleration
+28.0pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
3 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.11 | +19.7% |
| 2024 | 1.76 | +13.5% |
| 2023 | 1.55 | +10.2% |
| 2022 | 1.41 | -11.7% |
| 2021 | 1.60 | -4.8% |
| 2020 | 1.68 | -16.3% |
| 2019 | 2.00 | -20.7% |
| 2018 | 2.53 | -21.4% |
| 2017 | 3.21 | -10.9% |
| 2016 | 3.61 | - |